Contact UsInvestorsCareersMediaScienceContact Us

Women in Governance Awards Gold Level Gender Parity Certification to Pfizer Canada  


Company focused on fostering an equitable work culture for women at all levels

Kirkland, Quebec – March 8, 2023 – On International Women’s Day, Pfizer Canada is pleased to announce that it has been recognized for a second year with a gold level gender parity certification by Women in Governance (WiG). The WiG Parity Certification serves to recognize organizations that have achieved results by articulating a commitment to gender parity in the workplace, integrating it to the ecosystem of the organization and implementing mechanisms to achieve that commitment and sustain it over time. The certification is the result of a thorough evaluation by Women in Governance supported by Accenture, Mercer, and Willis Towers Watson.

“We are thrilled to be certified for a second year, which illustrates our deep commitment to gender parity at all levels of the organization,” says Najah Sampson, President, Pfizer Canada. “It is essential that we are continuously working to create and sustain a productive and positive workplace for women at Pfizer. It is also imperative to ensure we are meeting the needs of Canadians by embracing diverse viewpoints reflecting the patients and customers we serve.”

To achieve this certification, the organization is measured on three primary drivers:

  • Strategy - Governance and vision: The organization must demonstrate that its policies and practices, strategic direction, key decision-making, and the organization's culture are inclusive of a progressively equitable representation of women to men, while accounting for the multiple impacts of diversity in women’s career advancement.
  • Actions - Collective enablers: The organization must demonstrate that the practices, programs, and actions are geared to facilitating the progress towards equitable representation of diverse women at all levels of the company, until parity (reflecting all elements of diversity) is achieved and sustained.
  • Results - Equity: An organization must demonstrate that the outcome of its strategy and actions results in progression towards equity or parity in the distribution of women to men in terms of promotion, recruitment, and compensation at all hierarchical levels.

In the past year, Pfizer Canada has successfully achieved parity of women and men at the organization’s senior leadership level, which consists of 52% female members. Overall, at Pfizer Canada, 57% of those at director level and above are now women.

“At Pfizer Canada, our employees weave diversity, equity, and inclusion, including gender parity, into every action we take. This is articulated with solid and effective initiatives across the company that make our colleagues feel welcome and motivated to do more,” says Laura Larbalestier, head of People Experience at Pfizer Canada. “DEI is an important part of our workplace culture and continues to contribute to high rates of colleague engagement and retention.”

Pfizer Canada is consistently recognized as an employer of choice, including as a top employer for diversity, young people, and for families.
About Pfizer in Canada  
Pfizer Canada ULC is the Canadian operation of Pfizer Inc., one of the world's leading biopharmaceutical companies. Our diversified healthcare portfolio includes some of the world’s best known and most prescribed medicines and vaccines. We apply science and our global resources to improve the health and well-being of Canadians at every stage of life. Our commitment is reflected in everything we do, from our disease awareness initiatives to our community partnerships. To learn more about Pfizer Canada, visit or you can follow us on LinkedIn, Facebook, Twitter or YouTube.  


For Further Information  
Corporate Affairs Canada  
Pfizer Canada Media Line: 1-866-9Pfizer (1 866 973-4937)  
[email protected] 

About UsOur ProductsHelping Communities Our Voice Suppliers Distribution ChannelPfizer WorldwideMedia CentreTerms Of Use Careers Healthcare ProfessionalsContact UsPrivacy PolicyCopyright © Pfizer Canada 2022 All rights reserved. The information is intended only for residents of Canada. ® Pfizer Inc, used under license